Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Hein

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 25, 2010
Mammographic density as a risk factor for breast cancer in a German case-control studyKatharina Heusinger, Christian R Loehberg, Lothar Haeberle, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 12, 2010
Assessment of mammographic density before and after first full-term pregnancyChristian R Loehberg, Katharina Heusinger, Sebastian M Jud, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
BMC Cancer|November 16, 2011
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatmentPeter A Fasching, Katharina Heusinger, Lothar Haeberle, et al.
Der Gynakologe|March 24, 2021
[COVID-19 and pregnancy]Helmut Kleinwechter, Tanja Groten, Ute Schäfer-Graf, et al.
International Journal of Cancer|April 27, 2021
Association of genomic variants at PAX8 and PBX2 with cervical cancer riskDhanya Ramachandran, Yingying Wang, Peter Schürmann, et al.
Geburtshilfe Und Frauenheilkunde|June 9, 2018
Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart DataMarius Wunderle, Gregor Olmes, Naiba Nabieva, et al.
Breast Cancer Research and Treatment|May 15, 2013
Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factorsMichael P Lux, Christian M Bayer, Christian R Loehberg, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 11, 2014
Association of molecular subtypes with breast cancer risk factors: a case-only analysisClaudia Rauh, Paul Gass, Katharina Heusinger, et al.
Plos One|January 14, 2012
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionMichael G Schrauder, Reiner Strick, Rüdiger Schulz-Wendtland, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 25, 2010
Mammographic density as a risk factor for breast cancer in a German case-control studyKatharina Heusinger, Christian R Loehberg, Lothar Haeberle, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 12, 2010
Assessment of mammographic density before and after first full-term pregnancyChristian R Loehberg, Katharina Heusinger, Sebastian M Jud, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
BMC Cancer|November 16, 2011
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatmentPeter A Fasching, Katharina Heusinger, Lothar Haeberle, et al.
Der Gynakologe|March 24, 2021
[COVID-19 and pregnancy]Helmut Kleinwechter, Tanja Groten, Ute Schäfer-Graf, et al.
International Journal of Cancer|April 27, 2021
Association of genomic variants at PAX8 and PBX2 with cervical cancer riskDhanya Ramachandran, Yingying Wang, Peter Schürmann, et al.
Geburtshilfe Und Frauenheilkunde|June 9, 2018
Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart DataMarius Wunderle, Gregor Olmes, Naiba Nabieva, et al.
Breast Cancer Research and Treatment|May 15, 2013
Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factorsMichael P Lux, Christian M Bayer, Christian R Loehberg, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 11, 2014
Association of molecular subtypes with breast cancer risk factors: a case-only analysisClaudia Rauh, Paul Gass, Katharina Heusinger, et al.
Plos One|January 14, 2012
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionMichael G Schrauder, Reiner Strick, Rüdiger Schulz-Wendtland, et al.
Pageof 18